Elevance Health is a healthcare plan company located in Indiana, United States, which is part of the Healthcare sector, and is traded under the ticker ELV on the NYSE exchange.
Elevance Health stock last closed at $406.69, down 4.2% from the previous day, and has decreased 23.59% in one year. It has underperformed other stocks in the Healthcare Plans industry by 0.07 percentage points. Elevance Health stock is currently +12.28% from its 52-week low of $362.21, and -28.31% from its 52-week high of $567.26.
There are currently 227.35M shares of ELV outstanding. The market cap of ELV is $92.46B. In the past 24 hours, 2.29M ELV shares were traded.
How to Buy Elevance Health Stock
Wondering how to invest in Elevance Health stock? Here's how.
Decide where to buy Elevance Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Elevance Health stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your brokerage account: Select your payment method and add your info.
Research Elevance Health stock: The Elevance Health ticker symbol is ELV. Is Elevance Health stock a good investment? Should you buy shares of ELV? How do ELV's underlying business fundamentals look? Do top analysts think Elevance Health is a good buy? Why has ELV's stock price moved recently? (Hint: Our stock market research website can help you understand if ELV is a good stock to buy).
Execute your ELV buy order: Decide if you will purchase ELV shares at the current market price or use a limit order to purchase ELV stock at a given price.
Get the latest news on your ELV investment: Create a watchlist to keep tabs on your position in Elevance Health stock.
Step 1: Decide where to buy Elevance Health stock
You will need a brokerage account in order to access the NYSE market and buy ELV stock.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy ELV stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Elevance Health stock
After you have identified the best place to buy Elevance Health stock, it's crucial to research their stock prior to investing, so you actually understand the risk as well as the opportunity.
Elevance Health Numbers
ELV Price
$406.69
1w %
-7.82%
1y %
-23.59%
5y %
63.09%
P/E
15.76x
P/B
2.24x
P/S
0.52x
PEG
0.78x
Revenue
$177.01B
Earnings
$5.98B
Fore. Rev. Growth
8.15%
Fore. Earn. Growth
20.11%
Market Cap
$92.46B
Next Earnings
N/A
Next Dividend
N/A
Elevance Health Due Diligence Checks
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ELV's stock page.
Is ELV stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ELV's intrinsic value.
Using relative valuations metrics:
ELV could be undervalued based on its P/E ratio of 15.76x, relative to Healthcare Plans industry P/E ratio of 23.44x
ELV could be undervalued based on its P/B ratio of 2.24x, relative to Healthcare Plans industry P/B ratio of 2.47x
ELV could be undervalued based on its PEG ratio of 0.78x
ELV earnings of $9.10B is not enough to cover its interest payments.
There are more short-term assets than short-term liabilities on the ELV balance sheet.
There are more short-term assets than long-term liabilities on the ELV balance sheet.
Signs that ELV is not financially healthy:
ELV has a relatively high debt to equity ratio of 1.83.
Total ELV debt is higher than 5 years ago, relative to shareholder equity.
ELV's operating cash flow of $5.81B allows it to safely service it's debt of $31.23B.
ELV profit margin has gone down from 3.5% to 3.4% in the past year.
Is it a good time to buy Elevance Health stock, according to Wall Street analysts?
Out of 9 Wall Street analysts who monitor ELV, the consensus analyst rating on ELV is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent ELV Analyst Upgrades/Downgrades
Stephen Baxter, a bottom 23% analyst from Wells Fargo maintains ELV with a strong buy rating and lowers their ELV price target from $483.00 to $478.00, on Jan 28, 2025.
Sarah James, a bottom 3% analyst from Cantor Fitzgerald reiterates ELV with a strong buy rating and maintains their ELV price target from $485.00 to $485.00, on Jan 24, 2025.
Andrew Mok, a bottom 5% analyst from Barclays maintains ELV with a strong buy rating and raises their ELV price target from $501.00 to $512.00, on Jan 24, 2025.
Erin Wright, a top 4% analyst from Morgan Stanley maintains ELV with a strong buy rating and lowers their ELV price target from $643.00 to $551.00, on Oct 23, 2024.
Last year, ELV earnings were $5.98B. During the past five year, ELV's earnings have gone up by 6.53% per year. This was faster than the Healthcare Plans industry average of 0.94%.
Last year, ELV revenue was $177.01B. Over the last five year, ELV's revenue has increased by 11.18% per year. This was slower than the Healthcare Plans industry average of 11.18%.
Elevance Health pays a dividend of 1.62%, compared to the Healthcare Plans industry's average dividend yield of 1.7%. If you owned $1,000 worth of ELV stock, you would have received $16.23 in the past 12 months.
Elevance Health dividend payments have consistently grown over the past decade and have remained stable.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your ELV buy order
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually the easiest way to buy.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount, use a limit order.
Click the Open button and your broker will execute the order.
If you need more info about buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Elevance Health share?
As of Apr 21, 2025, it costs $406.69 to buy one share of Elevance Health stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.246 shares of ELV.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.